title: Systemic treatment of gastric and esophageal adenocarcinoma in elderly patients.
abstract: This article explores the treatment of cancer of the stomach and of the lower esophagus in older individuals. The incidence of both malignancies increases with age and, at present, the biology of the diseases, including sensitivity to chemotherapy, does not seem to change with age. The treatment of these cancers in patients 70 and over includes assessment of life expectancy secondary to physiologic age and evaluation of the individual's tolerance to stress. For this purpose a comprehensive geriatric assessment (CGA) is the best validated instrument. For individuals whose life expectancy without cancer exceeds that with cancer, the estimate of the risk of chemotherapy complications may reveal those patients in need of additional care and those patients in whom the risk of treatment may exceed the potential benefits. All older individuals receiving chemotherapy may need adjustment of the doses to the glomerular filtration rate, support with myelopoietic growth factors, and special care to prevent severe and irreversible neurotoxicity.
authors: Senior Adult Oncology Program, Moffitt Cancer Center, Tampa, FL 33618, USA.
authors: Lodovico
authors: L
authors: Balducci
keywords: Gastric and esophageal adenocarcinoma; elderly patients; systemic treatment
references: World J Gastroenterol. 2013 Dec 14;19(46):8714-21
references: 24379591
references: Dig Surg. 2013;30(2):150-8
references: 23867592
references: J Clin Oncol. 2011 Sep 1;29(25):3457-65
references: 21810685
references: J Cell Physiol. 2014 Nov;229(11):1575-6
references: 24664908
references: Cancer Control. 2014 Jul;21(3):215-20
references: 24955705
references: J Gerontol Nurs. 2005 Nov;31(11):28-35
references: 16320432
references: Gastroenterol Hepatol Bed Bench. 2013;6(Suppl 1):S11-8
references: 24834279
references: Ann Oncol. 2013 Oct;24 Suppl 7:vii36-40
references: 24001761
references: JAMA. 2012 Jan 11;307(2):182-92
references: 22235089
references: Eur J Cancer Prev. 2015 Jan;24(1):16-23
references: 24566154
references: J Clin Oncol. 2013 Apr 20;31(12):1576-82
references: 23509313
references: Crit Rev Oncol Hematol. 2013 Mar;85(3):257-65
references: 22948097
references: Prog Mol Biol Transl Sci. 2014;125:113-31
references: 24993700
references: J Transl Med. 2013 Mar 06;11:58
references: 23497313
references: J Am Geriatr Soc. 2014 May;62(5):901-6
references: 24697631
references: J Natl Compr Canc Netw. 2014 Jan;12(1):82-126
references: 24453295
references: J Gerontol A Biol Sci Med Sci. 2014 Feb;69(2):165-73
references: 23689826
references: N Engl J Med. 2010 Aug 19;363(8):733-42
references: 20818875
references: J Natl Cancer Inst. 2008 Aug 20;100(16):1184-7
references: 18695138
references: BMC Cancer. 2013 Nov 11;13:539
references: 24206575
references: Gastroenterol Clin North Am. 2013 Jun;42(2):261-84
references: 23639640
references: J Am Geriatr Soc. 2013 Mar;61(3):371-9
references: 23452034
references: J Surg Oncol. 2009 Jun 1;99(7):395-401
references: 19347884
references: Cancer. 2012 Jul 1;118(13):3377-86
references: 22072065